Baudax Bio, Inc. BXRX
Set alert
0.02 USD 0.00 0.00%
As of Feb 29, 3:53 PM ET
0.02 Day range 0.022025
0.0137 52-week range 3.47
- Open
- 0.0203
- Prev close
- 0.0218
- Mkt cap
- 0
- Vol
- 310.87K
- Avg vol
- 424.85K
- EPS
- -94.13
- P/E
- -0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.02
- High
- 0.022025
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 7, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
2Y chart
Events in this range
- Feb 16, 2022Split: 1 for 35
- Nov 8, 2022Earnings: —; estimate -21.2; surprise —%
- Dec 1, 2022Split: 1 for 40
- Feb 23, 2023Earnings: —; estimate 0; surprise —%
- May 12, 2023Earnings: —; estimate 5.75; surprise —%
- Aug 16, 2023Earnings: —; estimate -2.04; surprise —%
Signals (64)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 31, 2023 | 3 years ago |
| RSI: Oversold | Oct 27, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 16, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 11, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 6, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 7, 2023 | 3 years ago |
| RSI: Oversold | Aug 31, 2023 | 3 years ago |
| RSI: Oversold | Aug 18, 2023 | 3 years ago |
| SMA: Bearish | Aug 3, 2023 | 3 years ago |
| SMA: Bullish | Jul 31, 2023 | 3 years ago |
| SMA: Bearish | Jul 28, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 30, 2023 | 3 years ago |
| RSI: Overbought | Jun 30, 2023 | 3 years ago |
| RSI: Oversold | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | May 19, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 27, 2023 | 3 years ago |
| SMA: Bearish | Apr 26, 2023 | 3 years ago |
| SMA: Bullish | Apr 25, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 18, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 16, 2023 | 3 years ago |
| RSI: Oversold | Mar 9, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 10, 2023 | 3 years ago |
| SMA: Bearish | Feb 8, 2023 | 3 years ago |
| SMA: Bullish | Feb 7, 2023 | 3 years ago |
| SMA: Bearish | Jan 25, 2023 | 3 years ago |
| SMA: Bullish | Jan 24, 2023 | 3 years ago |
| MACD: Buy Signal | Dec 22, 2022 | 3 years ago |
| RSI: Oversold | Dec 16, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 14, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 9, 2022 | 3 years ago |
| MACD: Sell Signal | Dec 5, 2022 | 3 years ago |
| RSI: Oversold | Dec 5, 2022 | 3 years ago |
| RSI: Oversold | Nov 18, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 15, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 11, 2022 | 3 years ago |
| RSI: Oversold | Nov 9, 2022 | 3 years ago |
| RSI: Oversold | Oct 19, 2022 | 4 years ago |
| RSI: Oversold | Oct 17, 2022 | 4 years ago |
| RSI: Oversold | Oct 7, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 16, 2022 | 4 years ago |
| RSI: Oversold | Aug 30, 2022 | 4 years ago |
| RSI: Oversold | Aug 23, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 10, 2022 | 4 years ago |
| SMA: Bullish | Aug 9, 2022 | 4 years ago |
| SMA: Bearish | Aug 4, 2022 | 4 years ago |
| SMA: Bullish | Aug 3, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 3, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 19, 2022 | 4 years ago |
| RSI: Oversold | Jun 2, 2022 | 4 years ago |
| MACD: Buy Signal | May 31, 2022 | 4 years ago |
| RSI: Oversold | May 18, 2022 | 4 years ago |
| MACD: Sell Signal | May 10, 2022 | 4 years ago |
| RSI: Oversold | May 9, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 11, 2022 | 4 years ago |
| RSI: Oversold | Feb 25, 2022 | 4 years ago |
| RSI: Oversold | Feb 18, 2022 | 4 years ago |
| MACD: Sell Signal | Feb 17, 2022 | 4 years ago |
| RSI: Oversold | Feb 16, 2022 | 4 years ago |
| RSI: Oversold | Jan 26, 2022 | 4 years ago |
| MACD: Buy Signal | Jan 13, 2022 | 4 years ago |
| RSI: Oversold | Dec 28, 2021 | 4 years ago |
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Mar 7, 2024
Expected Mar 7, 2024. Consensus EPS estimate 0.00.
Financials — quick view
BXRX Revenue — quarterly 0
BXRX Net income — quarterly -1.93M
BXRX EPS — quarterly -0.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 7, 2024 | Dec 1, 2023 | -0.12 | — | — | — |
| Nov 20, 2023 | Sep 1, 2023 | -0.53 | — | — | — |
| Aug 16, 2023 | Jun 1, 2023 | -2.04 | — | — | — |
| May 12, 2023 | Mar 1, 2023 | 5.75 | — | — | — |
| Feb 23, 2023 | Dec 1, 2022 | 0.00 | — | — | — |
| Nov 8, 2022 | Sep 1, 2022 | -21.20 | — | — | — |
News
- Baudax Bio Announces Corporate Update
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Wednesday
- Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
- Why Is Baudax Bio (BXRX) Stock Up 75% Today?
- Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Baudax Bio shares rocket as lead clinical candidate gains FDA orphan drug designation
- Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
- Here's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock Now
Your note
Sign in to keep a note on BXRX — it syncs with the Stock Master app.